Study reveals how SARS-CoV-2 variants lose Infectivity in aerosols: pH and salt content key factors

FHS
June 27, 2023
2:36 am

Research examines the stability of SARS-CoV-2 variants in aerosols, finding significant decay in infectivity over time. pH and salt content play a role in virus stability.

Sanofi and Regeneron’s Dupixent scores second win in Phase III COPD trial

Share this article Dupixent is an interleukin-4 receptor alpha antagonist monoclonal antibody. Image Credit: Net Vector / Shutterstock. Sanofi and Regeneron have reported positive interim

November 27, 2023

NB-4746 by Nura Bio for Amyotrophic Lateral Sclerosis: Likelihood of Approval

NB-4746 is under clinical development by Nura Bio and currently in Phase I for Amyotrophic Lateral Sclerosis.

December 26, 2024

Stem cell therapy trial shows promise for regenerative treatment of heart failure

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.